
This drug is a glucocorticoid used as an anti-inflammatory and immunosuppressant. Ourteam of highly experienced workforce supports us in offering our clients Deflazacort. This drug is used to treat duchenne muscular dystrophy in adults and children 5 years of age and older. It is in a class of medications called corticosteroids. It works by reducing inflammation and by changing the way the immune system works. Deflazacort comes as a tablet and a suspension (liquid) to take by mouth. It is usually taken once a day with or without food.
Features:
Deflazacort is a glucocorticoidused as an anti-inflammatory and immunosuppressant. It was patented in 1965 andapproved for medical use in 1985. The U.S. Food and Drug Administrationconsiders it to be a first-in-class medication. CAS ID: 14484-47-0 Formula: C25H31NO6 Trade name: Emflaza, Calcort, others Eliminationhalf-life: 1.1–1.9 hours (metabolite) Metabolism: By plasma esterases,to active metabolite ATC code: H02AB13 (WHO) AS number: 14484-47-0Chemical Name: 11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione21-acetate, Deflazacort (CAS No.: 14484-47-0)Pharmacopeia: In House synonym 11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione21-acetate, Deflazacort (CAS No.: 14484-47-0) MolecularFormula C25H31NO6 MolecularWeight 441.52 Specifications Availableon request Packing Exportworthy packing MaterialSafety Data Sheet
Availableon request |